LDS/Medical Tests/Fungal and Yeast Diagnostic Panel, Antigen Detection

Fungal and Yeast Diagnostic Panel, Antigen Detection

Fungal infections are very common and typically are superficial infections, meaning they only affect skin or mucus membranes such as the mouth (oral thrush), vagina (yeast vaginitis), or athlete’s foot. Often these superficial infections are not considered a threat to life, but can be easily spread and affect a person’s quality of life. These infections can be easily diagnosed and treated. However, if a fungus causes infection of the blood or lungs, it is more serious and termed a systemic infection (invasive). Systemic fungal infections are considered life threatening and can be more difficult to treat. Typically systemic infections occur in those who have weakened immune systems. It can also occur in geographical regions where certain fungi are very common. As an example, histoplasma is very common in the Central and Eastern U.S.  Unlike superficial fungal infections, systemic infections are not as easily diagnosed. In order to aid a physician in diagnosing a fungal infection, a fungal panel may be performed. A fungal panel tests for multiple fungal pathogens. A fungal panel may include:

Cryptococcus Antigen: Cryptococcosis is caused by Cryptococcus neoformans (a dimorphic yeast-like organism), which is associated with bird droppings. Cryptococcus neoformans is acquired by inhalation of the microorganism, causing pneumonia in immunosuppressed patients (such as patients with HIV). Cryptococcus can cause meningitis and can be disseminated to other organs such as bone, kidney, and skin.

Blastomyces Antigen: Blastomycosis is caused by the dimorphic fungus Blastomyces dermatitidis. Typically Blastomyces affects the pulmonary system, which presents with cough, pain, bloody sputum, and fever. Blastomyces dermatitidis grows as a white mold and is usually found in the soil near water, mainly in the southeastern and south central United States where the land is mostly marsh. Typically Blastomyces dermatitidis produces spores, which are dispersed by the wind or disturbing the soil. Spores convert to yeast when they are inhaled by a host and find themselves at body temperature in a moist environment, thus leading to infection. Although the most common manifestation of the disease is pneumonia-like symptoms, the infection may spread to the skin, bone, or brain and cause swelling and lesions. In those infected with this organism, approximately 50% are asymptomatic. When left untreated the disease can be fatal.

Histoplasma Antigen: Histoplasmosis is the most common systemic fungal infection and typically begins as a pulmonary infection with influenza-like symptoms. Histoplasmosis is caused by the organism Histoplasma capsulatum and primarily affects the lungs of infected individuals, but has also been known to cause cutaneous infections. The infection often resolves but it may cause severe disease in re-infections. Infection with H. capsulatum is commonly seen in the Mississippi and Ohio River valleys, but may occur in other regions. H. capsulatum is a thermally dimorphic fungus found as a brown mycelium. It grows mainly in soil, and in areas contaminated with bat or bird droppings (guano), therefore it has been referred to as cave disease and spelunker's disease.

Candida Antigen: Candida albicans is considered the most common cause of fungal diseases. Candida genus is among one of the most common causes of vaginitis in women of childbearing age. C. albicans is normally present in skin, mouth, vagina, and intestine, and it can flourish when changes occur in the microbial population. Also of note, while being an endogenous inhabitant of the mucocutaneous regions and the alimentary tract, it can easily become an opportunistic pathogen in immunocompromised patients. Infection is usually localized in forms of oral candidiasis, vulvovaginitis, etc.; however, it can become systemic in rare circumstances if the yeast enters the blood or internal organs such as those in immunocompromised patients (HIV, transplant patients, etc). Candidiasis of the intestines may develop due to use of antibiotics. When bacterial conditions that are normally found in this organ are disrupted, the yeast can overpopulate and cause disease.

Coccidioides Antigen: Coccidioidomycosis, also known as Valley Fever, is a fungal infection that is found in the southwestern United States, including Southern California, Arizona, Central and South America. The infection is caused by the thermally dimorphic fungus Coccidioides immitis or Coccidioides posadasii. Coccidioidomyocosis occurs by breathing in spores from the soil. The most common clinical presentation of coccidioidomycosis is pneumonia that becomes evident 1 – 3 weeks after infection. The cause of the pneumonia is difficult to distinguish from other sources and is usually only diagnosed after the other causes are ruled out. Coccidioidal pneumonia, although self-limiting, can have severe symptoms such as chest pain, fever, and rashes. If left untreated in immunocompromised patients such as HIV or organ transplant patients, the coccidioides may become disseminated and spread throughout the body, causing bone pain, joint pain, heart inflammation, or meningitis. Occasionally Coccidioides immitis/ posadasii can cause skin lesions if there has been contact with a cut or sore on the skin caused by Coccidioides.

Aspergillus Antigen: Aspergillus molds are found worldwide, especially in the autumn and winter in the Northern Hemisphere. Most people are naturally immune and do not develop disease caused by Aspergillus. Aspergillus is a ubiquitous fungus that causes a variety of clinical syndromes in the lung, ranging from allergy-like illness, aspergilloma in patients with lung cavities, or chronic necrotizing aspergillosis in those who are mildly immunocompromised or have chronic lung disease. Invasive pulmonary aspergillosis (IPA) is a serious and often fatal infection in HIV-infected and other immunocompromised patients, and in patients who have undergone organ or stem cell transplantation. Delayed diagnosis and therapy may lead to poor outcomes.

Cryptococcus Antigen:

  • In diagnosis of cryptococcal meningitis in HIV and immunosuppressed patients
  • Monitor response of cryptococcal meningitis to therapy
  • As an aid in diagnosis of respiratory infection caused by Cryptococcus neoformans 

Blastomyces Antigen:

  • Diagnosis of blastomyces infection
  • Diagnosis of Blastomyces dermatitidis
  • Diagnosis of diseases related to blastomyces infection in immunocompromised patients 

Histoplasma Antigen:

  • As an aid in diagnosis of disseminated histoplasmosis
  • Differential diagnosis of histoplasmosis from other fungal infections such as blastomycosis and coccidioidomycosis
  • Monitor therapy 

Candida Antigen:*

  • As an aid in diagnosing Candidiasis (yeast infection)
  • Differential diagnosis infection with C. albicans in immunocompromised patients
  • Monitoring therapy treatment 

Coccidioides Antigen:*

  • Diagnosis and treatment monitoring of coccidioidomycosis
  • Differential diagnosis of coccidioidomycosis in immunocompromised and HIV patients 

Aspergillus Antigen:*

  • Diagnosis of invasive pulmonary aspergillosis in immunosuppressed patients
  • Differential diagnosis of pulmonary aspergillosis from other pulmonary infections

Note: Testing should be performed when pulmonary or neurologic symptoms are present and the patient lives in or has recently traveled to an endemic area.

Cryptococcus Antigen

Postitive in:

  • Cryptococcal infection
  • Cryptococcal meningitis in HIV and immunosuppressed patients
  • Cryptococcal respiratory infection

Blastomyces Antigen

Postitive in:

  • Blastomycosis
  • Blastomyces dermatitis
  • Blastomyces infection in immunocompromised patients

Histoplasma Antigen

Positive in:

  • Disseminated histoplasmosis
  • Localized (tissue specific) disease

Candida Antigen

Increased in:

  • Candidiasis
  • Immunocompromised patients infected with C. albicans

Coccidioides Antigen

Positive in:

  • Coccidioides infections

Aspergillus Antigen

Increased in:

  • Aspergillus infections

Note: Histoplasmosis, coccidioidomycosis, blastomycosis and C-reactive protein may cause false positives.

Cryptococcus Antigen: Negative

Blastomyces Antigen: Negative

Histoplasma Antigen: Negative

Candida Antigen: Negative

Coccidioides Antigen: Negative

Aspergillus Antigen: Negative

 

 

Cryptococcus Antigen: Enzyme immunoassay (EIA) with reflex to Latex agglutination
Blastomyces Antigen: Enzyme Immunoassay (EIA)
Histoplasma Antigen: Enzyme Immunoassay (EIA)
Candida Antigen: Latex agglutination
Aspergillus Antigen:Enzyme Immunoassay (EIA)
Coccidioides Antigen: Enzyme Immunoassay (EIA)
H. capsulatum antibody, H. capsulatum culture, H. capsulatum by PCR, tissue biopsy histology

Cryptococcus Antigen:Serum (SST) and/or Cerebrospinal fluid
Blastomyces Antigen: Serum or Urine
Histoplasma Antigen: Serum (SST), Whole Blood EDTA (Lavender), ACD (Yellow), Urine
Candida Antigen: Serum
Coccidiodes Antigen: Serum, cerebrospinal fluid
Aspergillus Antigen: Serum or plasma

Cerebrospinal Fluid (CSF) Analysis; Fungal Culture, Fungal Stain - KOH with Calcofluor-White to identify and differentiate Fungus, Blood or CSF Culture, Bacterial Antigens and Mycobacterial Culture to rule out Bacterial and Mycobacterium infection, Fungal culture from biopsy or sputum, Candida antibodies by immunodiffusion, Candida species by PCR, Coccidioides immitis by PCR, Skin Test, Complement Fixation Test, Fungal DNA by PCR.

3- 5 days. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Infect Dis Clin North Am. 2001;15:567. [PMID: 11447710]
  • J Infect Chemother. 2005 Jun;11(3):115-22. [PMID: 15990974]
  • J Infect. 2005 Dec; 51(5):e289-97. [PMID: 16321643]
  • Annu Rev Microbiol. 2006;60:69-105. [PMID: 16704346]
  • SeminRespirCrit Care Med. 2008 Apr;29(2):174-81. [PMID: 18365999]
  • JAMA. 1999; 282(1):21-22. [PMID: 10404898]
  • ClinMicrobiol Rev. 2007 Jan; 20(1):115-32. [PMID: 17223625]
  • ClinMicrobiol Rev. 2002;15: 465. [PMID: 12097252]
  • J AntimicrobChemother. 2002;49(Suppl 1):11. [PMID: 11801576]
  • SeminRespir Infect. 2002;17: 158. [PMID: 12070835]
  • DiagnMicrobiol Infect Dis. 2006;54:283. [PMID: 16466889]
  • Clin Infect Dis. 2005;41:1217. [PMID: 16206093]
  • Clin Infect Dis. 2006;42:103. [PMID: 16323099]
  • Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).
  • Stevens, Christine Dorresteyn. Clinical Immunology & Serology A Laboratory Perspective 3rd edition. Philadelphia: F.A. Davis Company. 2010.
  • Koneman EW, Allen SD, Janda WM, Schreckenberger PC, and Winn WC Jr. Color Atlas and Testbook of Diagnostic Microbiology. Philadelphia. Lippincott (1997).
  • J Microbiol. 2005 Feb;43 Spec No:65-84.